<?xml version="1.0" encoding="UTF-8"?>
<p>MBL has also exhibited therapeutic potential with recombinant chimeric versions inhibiting IAV both 
 <italic>in vitro</italic> (through complement activation and induction of viral aggregation [
 <xref rid="B178" ref-type="bibr">178</xref>]) and in mice (in part, by balancing cytokine and inflammatory responses [
 <xref rid="B179" ref-type="bibr">179</xref>]).
</p>
